A detailed history of Ameriprise Financial Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Ameriprise Financial Inc holds 2,089,589 shares of EW stock, worth $154 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,089,589
Previous 3,202,730 34.76%
Holding current value
$154 Million
Previous $296 Million 53.39%
% of portfolio
0.04%
Previous 0.08%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$59.7 - $93.78 $66.5 Million - $104 Million
-1,113,141 Reduced 34.76%
2,089,589 $138 Million
Q2 2024

Aug 14, 2024

BUY
$84.3 - $94.31 $63 Million - $70.5 Million
747,771 Added 30.46%
3,202,730 $296 Million
Q1 2024

May 15, 2024

BUY
$72.54 - $95.56 $46 Million - $60.6 Million
633,858 Added 34.81%
2,454,959 $235 Million
Q4 2023

Feb 14, 2024

BUY
$61.71 - $77.76 $8.41 Million - $10.6 Million
136,290 Added 8.09%
1,821,101 $139 Million
Q3 2023

Nov 14, 2023

SELL
$69.28 - $93.38 $29 Million - $39.1 Million
-418,967 Reduced 19.91%
1,684,811 $117 Million
Q2 2023

Aug 14, 2023

SELL
$81.41 - $94.33 $7.83 Million - $9.07 Million
-96,130 Reduced 4.37%
2,103,778 $198 Million
Q1 2023

May 15, 2023

BUY
$74.26 - $84.51 $1.57 Million - $1.78 Million
21,090 Added 0.97%
2,199,908 $182 Million
Q4 2022

Feb 14, 2023

SELL
$68.3 - $87.44 $84.5 Million - $108 Million
-1,237,435 Reduced 36.22%
2,178,818 $163 Million
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $35.2 Million - $45.8 Million
-426,967 Reduced 11.11%
3,416,253 $283 Million
Q2 2022

Aug 15, 2022

BUY
$86.5 - $128.27 $75.5 Million - $112 Million
873,155 Added 29.4%
3,843,220 $365 Million
Q1 2022

May 16, 2022

BUY
$101.96 - $128.34 $21.9 Million - $27.5 Million
214,484 Added 7.78%
2,970,065 $348 Million
Q4 2021

Feb 14, 2022

SELL
$106.37 - $130.68 $58.6 Million - $72 Million
-551,182 Reduced 16.67%
2,755,581 $355 Million
Q3 2021

Nov 15, 2021

SELL
$102.91 - $122.75 $181 Million - $216 Million
-1,757,652 Reduced 34.71%
3,306,763 $374 Million
Q2 2021

Aug 16, 2021

BUY
$83.84 - $104.76 $2.81 Million - $3.51 Million
33,525 Added 0.67%
5,064,415 $524 Million
Q1 2021

May 17, 2021

BUY
$78.68 - $90.67 $109 Million - $125 Million
1,381,907 Added 37.87%
5,030,890 $421 Million
Q4 2020

Feb 12, 2021

SELL
$71.69 - $91.23 $12.5 Million - $15.9 Million
-174,265 Reduced 4.56%
3,648,983 $333 Million
Q3 2020

Nov 16, 2020

SELL
$67.19 - $87.44 $5.29 Million - $6.89 Million
-78,747 Reduced 2.02%
3,823,248 $305 Million
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $158 Million - $211 Million
2,740,924 Added 236.07%
3,901,995 $270 Million
Q1 2020

May 15, 2020

SELL
$52.41 - $81.0 $19.4 Million - $29.9 Million
-369,643 Reduced 24.15%
1,161,071 $219 Million
Q4 2019

Feb 14, 2020

SELL
$71.7 - $82.09 $10.9 Million - $12.5 Million
-151,811 Reduced 9.02%
1,530,714 $357 Million
Q3 2019

Nov 14, 2019

SELL
$61.55 - $75.43 $12 Million - $14.7 Million
-194,955 Reduced 10.38%
1,682,525 $370 Million
Q2 2019

Aug 14, 2019

SELL
$55.74 - $64.41 $2.15 Million - $2.48 Million
-38,559 Reduced 2.01%
1,877,480 $347 Million
Q1 2019

May 15, 2019

SELL
$47.89 - $64.05 $12.9 Million - $17.2 Million
-269,112 Reduced 12.32%
1,916,039 $367 Million
Q4 2018

Feb 14, 2019

SELL
$46.41 - $56.94 $2.68 Million - $3.29 Million
-57,726 Reduced 2.57%
2,185,151 $334 Million
Q3 2018

Nov 14, 2018

SELL
$45.7 - $58.03 $4.24 Million - $5.39 Million
-92,874 Reduced 3.98%
2,242,877 $390 Million
Q2 2018

Aug 14, 2018

SELL
$42.45 - $51.3 $24.4 Million - $29.5 Million
-575,355 Reduced 19.76%
2,335,751 $340 Million
Q1 2018

May 15, 2018

SELL
$37.19 - $47.45 $32.9 Million - $42 Million
-884,260 Reduced 23.3%
2,911,106 $406 Million
Q4 2017

Feb 12, 2018

SELL
$33.79 - $39.39 $14.7 Million - $17.2 Million
-436,109 Reduced 10.31%
3,795,366 $428 Million
Q3 2017

Nov 07, 2017

BUY
$36.29 - $38.83 $154 Million - $164 Million
4,231,475
4,231,475 $463 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45.7B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.